As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

BioNTech SE Sponsored ADR (BNTX) shares ended the last trading session 6% higher at $102.34. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high estimate of $172.00, and a low estimate of $139.00. Observing a 2.32% increase, ...

Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. One year after securing a chance to co-develop the prospect, BioNTech let the option expire as part of its ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

BioNTech (NasdaqGS:BNTX) saw its share price increase by 11%, coinciding with significant market activity and major index gains. While the company itself did not have any significant news or ...